Literature DB >> 8634756

Simultaneous determination of oxalic and citric acids in urine by high-performance liquid chromatography.

M H Khaskhali1, M I Bhanger, F D Khand.   

Abstract

A simple method for the simultaneous determination of oxalic and citric acids had been developed using reversed-phase HPLC. An aqueous solution containing potassium dihydrogen phosphate (0.25%) and tetrabutylammonium hydrogen sulphate (2.5 mmol) at pH 2.0 was used as mobile phase. Under these conditions both the components were well resolved and detected at 210 nm. The recovery for oxalic and citric acids was 97% and 102%, respectively. The method presented here was applied to urine specimens of a large number of urolithic patients and control subjects. Because of the simplicity of the method its application provides better means of monitoring the concentration of oxalic and citric acids in the formation of renal calculi.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634756     DOI: 10.1016/0378-4347(95)00338-x

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  3 in total

1.  In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Authors:  Pajaree Chariyavilaskul; Poonsin Poungpairoj; Suchada Chaisawadi; Chanchai Boonla; Thasinas Dissayabutra; Phisit Prapunwattana; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2015-01-15       Impact factor: 3.436

2.  Oxalic acid and sclerotial differentiation of Polyporus umbellatus.

Authors:  Yong-Mei Xing; Wan-Qiang Yin; Meng-Meng Liu; Chun-Lan Wang; Shun-Xing Guo
Journal:  Sci Rep       Date:  2015-06-01       Impact factor: 4.379

3.  Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.

Authors:  Ying Shen; Xia Luo; Huijun Li; Qing Guan; Liming Cheng
Journal:  J Clin Lab Anal       Date:  2021-06-07       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.